have found reduced SIRT1 expression in several types of cancer (glioblastoma, bladder carcinoma, prostate carcinoma, ovarian cancer, and hepatic carcinoma), compared to the corresponding normal tissues [46]. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.